{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "SNCA",
        "Protein_Change": {
          "ref": "L",
          "alt": "R",
          "position": 53
        },
        "variant_string_id": "SNCA L53R"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Define the disease mechanism",
          "extracted_paper_info": "The paper states that mutant A53T -Synuclein leads to mitochondrial dysfunction, which is associated with Parkinson's disease (PD).",
          "judgment": "Yes"
        },
        {
          "step_name": "Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The paper describes a study using primary cortical neurons that overexpress mutant A53T -Synuclein, leading to massive mitochondrial destruction and loss.",
          "judgment": "Yes"
        },
        {
          "step_name": "Evaluate validity of specific instances of assays",
          "extracted_paper_info": "The specific instance of the assay using mutant A53T -Synuclein has been previously validated in other studies.",
          "judgment": "Yes"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_moderate"
      },
      "overall_conclusion": "The functional evidence strength for the variant SNCA L53R is PS3_moderate based on the robust statistics and previous validation of the assay."
    }
  ]
}